Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
L. Salleras, A. Dominguez, N. Cardenosa.
Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) alter a mass vaccination campaign with meningococcal C conjugated vaccine.
Vaccine, 21 (2003), pp. 729-733
[2.]
Q. Zhang, E. Pettitt, R. Burkinshaw, G. Race, L. Shaw, A. Finn.
Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants.
Pediatr Infect Dis J, 21 (2002), pp. 209-213
[3.]
I. Pereiro, J. Díez-Domingo, A. Morant, C. Gimeno, M. Lerma, M. San-Martin, et al.
Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine.
Scand J Infect Dis, 33 (2001), pp. 581-584
[4.]
A. González de Aledo, J. García Merino.
Seroprevalencia de anticuerpos bactericidas frente al meningococo C en Cantabria despues de la campana de vacunacion.
Rev Esp Salud Publica, 72 (1998), pp. 365-374
[5.]
E. Delgado, J. Vázquez, J. García, J. González, F. Martínez, S. Berron, et al.
Niveles de anticuerpos bactericidas contra meningococo C despues de la vacunacion a niños entre 2 y 6 anos en Andalucia.
Rev Esp Salud Publica, 74 (2000), pp. 433-444
[6.]
B. Alcalá, J. Vázquez.
Situación de la cepa epidémica de Neisseria Meningitidis C:2b:P1.2,5 despues de la vacunacion A+C.
Rev Esp Salud Publica, 74 (2000), pp. 377-379
[7.]
M. Goicoechea, A. Fullana, P. Momparler, M.J. Redondo, J. Brines, F. Bueno.
Evolución de la enfermedad meningococica en la poblacion infantil de la Comunidad Valenciana (1996–2000). Efectividad de la vacunacion meningococica A+B.
Rev Esp Salud Publica, 77 (2003), pp. 125-142
[8.]
S.A. Skull, J.R. Butler.
Meningococcal vaccination for adolescents? An economic evaluation in Victoria.
J Pediatr Child Health, 37 (2001), pp. 28S-33S
[9.]
Q. Zhang, R. Lakshman, R. Burkinshaw, S. Choo, J. Everard, S. Akhtar, et al.
Primary and Booster mucosal Immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to University students in the United Kingdom.
Infect Immun, 69 (2001), pp. 4337-4341
[10.]
P. Richmond, E. Keczmarski, R. Borrow, J. Findlow, S. Clark, R. McCann, et al.
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
J Infect Dis, 181 (2000), pp. 761-764
[11.]
A.J. Pollard, M. Levin.
Vaccines for prevention of meningococcal disease.
Pediatr Infec Dis J, 19 (2000), pp. 333-345
[12.]
J.A. Váazquez.
Evaluación de la campana de inmunización frente a meningococo de serogrupo C en España.
An Esp Pediatr, 57 (2002), pp. 3-6
[13.]
P. Balmer, R. Borrow, E. Millar.
Impact of meningococcal C conjugate vaccine in the UK.
J Med Microbiol, 51 (2002), pp. 717-722
[15.]
C.L. Trotter, M.E. Ramsay, E.B. Kaczmarski.
Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.
Commun Dis Public Health, 5 (2002), pp. 220-225
[16.]
J.M. McLennan, F. Shackley, P.T. Heath, J.J. Deeks, C. Flamank, M. Herbert, et al.
Safety, immunogenicity and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.
Jama, 283 (2000), pp. 2795-2801
[17.]
P. Richmond, R. Borrow, D. Goldblatt, J. Findlow, S. Martin, R. Morris, et al.
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
J Infect Dis, 183 (2001), pp. 160-163
[18.]
M.E. Ramsay, N.J. Andrews, C.L. Trotter, E.B. Kaczmarski, E. Miller.
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.
Bmj, 326 (2003), pp. 365-366
[19.]
A. Bose, P. Coen, J. Tully, R. Viner, R. Booy.
Effectiveness of meningococcal C conjugate vaccine in teenagers in England.
Lancet, 361 (2003), pp. 675-676
[20.]
L. Salleras, A. Dominguez, N. Cardenosa.
Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain.
Vaccine, 21 (2003), pp. 725-728
[21.]
Generalitat Valenciana.
Vacuna conjugada contra el menincococo serogrupo C.
Monografia sanitaria, serie E, n.° 32,
[22.]
J. McLennan, S. Obaro, J. Deeks, D. Lake, C. Elie, G. Carlone, et al.
Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
J Infect Dis, 183 (2001), pp. 97-104
[23.]
R. Borrow, D. Goldblatt, N. Andrews, J. Southern, L. Ashton, S. Deane, et al.
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom.
J Infect Dis, 186 (2002), pp. 1353-1357
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados